Effect of nalbuphine hydrochloride on the active phase during first stage of labour: A pilot study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, T. -H. | - |
dc.contributor.author | Kim, J. -M. | - |
dc.contributor.author | Lee, H. -H. | - |
dc.contributor.author | Chung, S. -H. | - |
dc.contributor.author | Hong, Y. -P. | - |
dc.date.accessioned | 2021-08-12T04:46:40Z | - |
dc.date.available | 2021-08-12T04:46:40Z | - |
dc.date.issued | 2011-11 | - |
dc.identifier.issn | 0144-3615 | - |
dc.identifier.issn | 1364-6893 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/16126 | - |
dc.description.abstract | The aim of this pilot study was to determine whether nalbuphine shortens the duration of the active phase during the first stage of labour in pregnant women. Among 1,619 deliveries, we enrolled 302 pregnant women between March 2003 and August 2005. The case group received a nalbuphine injection (n = 57), while the remaining patients served as a control group (n = 245). The effects of nalbuphine on the length of labour were analysed using a survival analysis (log-rank test). The average duration of the initial active phase was 75 and 160 min for the case and control groups, respectively. The reduced duration of the active phase in the case group occurred regardless of oxytocin infusion (p < 0.01) and was without significant risks. | - |
dc.format.extent | 4 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Taylor & Francis | - |
dc.title | Effect of nalbuphine hydrochloride on the active phase during first stage of labour: A pilot study | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.3109/01443615.2011.602139 | - |
dc.identifier.scopusid | 2-s2.0-81255207783 | - |
dc.identifier.wosid | 000297059600013 | - |
dc.identifier.bibliographicCitation | Journal of Obstetrics and Gynaecology, v.31, no.8, pp 724 - 727 | - |
dc.citation.title | Journal of Obstetrics and Gynaecology | - |
dc.citation.volume | 31 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 724 | - |
dc.citation.endPage | 727 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Obstetrics & Gynecology | - |
dc.relation.journalWebOfScienceCategory | Obstetrics & Gynecology | - |
dc.subject.keywordPlus | PHARMACOKINETICS | - |
dc.subject.keywordPlus | REMIFENTANIL | - |
dc.subject.keywordPlus | PARTURITION | - |
dc.subject.keywordPlus | FENTANYL | - |
dc.subject.keywordAuthor | Duration of labour | - |
dc.subject.keywordAuthor | nalbuphine hydrochloride | - |
dc.subject.keywordAuthor | survival analysis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.